Marathon Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$8.64M |
| 2 |
Phillips 66
PSX
|
+$7.89M |
| 3 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
+$6.41M |
| 4 |
HDSN
Hudson Technologies
HDSN
|
+$5.74M |
| 5 |
LAND
Gladstone Land Corp
LAND
|
+$3.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$4.45M |
| 2 |
CMBT
CMB.TECH NV
CMBT
|
+$1.15M |
| 3 |
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
|
+$765K |
| 4 |
Illumina
ILMN
|
+$484K |
| 5 |
Chevron
CVX
|
+$405K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 35.42% |
| 2 | Technology | 19.42% |
| 3 | Industrials | 10.26% |
| 4 | Healthcare | 10.05% |
| 5 | Energy | 6.62% |
Similar funds
Marathon Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Marathon Capital Management held 164 positions worth $350M, up 13% from $310M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Marathon Capital Management deployed $59.2M of net new capital in Q3 2022, opening 18 new positions and adding to 40 existing holdings. Its largest new stake was Gladstone Land Corp: 156,325 shares worth $2.83M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, down from 43% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was CMB.TECH NV, an estimated $1.15M trimmed.
- Marathon Capital Management's largest Q3 2022 buy was Gladstone Land Corp: 156,325 shares worth $2.83M.
- Marathon Capital Management added most to Enphase Energy in Q3 2022, an estimated $8.64M increase.
- Marathon Capital Management's biggest Q3 2022 reduction was CMB.TECH NV, cutting an estimated $1.15M.
- Marathon Capital Management fully exited GSK in Q3 2022, selling an estimated $4.45M.
- Marathon Capital Management's ten largest holdings make up 51% of its $350M portfolio in Q3 2022.
- Marathon Capital Management opened 18 new positions and closed 10 in Q3 2022.
- Marathon Capital Management's portfolio value rose 13% quarter-over-quarter to $350M.
Based on Marathon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.